WEMADE
11.1.2024 10:10:28 CET | Business Wire | Press release
Global pre-registration for ‘NIGHT CROWS’, a game published by Wemade and developed by MADNGINE, began on January 11th.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240110750299/en/
Wemade opens global pre-registration for ‘NIGHT CROWS’ (Graphic: Wemade)
NIGHT CROWS is an MMORPG based on Unreal Engine 5 that supports cross-play between mobile and PC platforms. Realistic light source illumination and high-quality graphics, 4 classes and 8 sub-classes that amplify user choice and effort, Dynamic combat encompassing ground and air using Gliders, Large-scale war from 1,000 players in realistic and vast fields in ”Battlefront” content, and more are included in the game. After its release in the Republic of Korea in April 2023, the game reached No. 1 in most downloads and top sales charts in major mobile app markets.
Pre-registration will be open until the official launch in March on the official website, Google Play, and Apple App Store. Abundant pre-registration rewards include a rare-grade Mount, Glider, and more.
Wemade has utilized blockchain technology to implement multi-tokenomics with the tokenization of core in-game items in NIGHT CROWS. The in-game economy will also be interconnected with Character NFTs, each NFT created through the compression of the character and user's game data.
As the game will be connected with WEMIX3.0 at the center following an omnichain network strategy, users of other blockchain networks will be able to easily utilize the tokenomics as well.
Also implemented will be the “SSS (Streamer Supporting System).” SSS is a transparent support system in which users of Wemade games, Streamers who create content related to Wemade games, and Supporters who support Streamers can co-exist. Pre-registration rewards for SSS Streamers include a rare-grade Glider with special looks.
Additionally, the NFT Collection ‘The Night is Coming’ will be sold in celebration of pre-registration on the WEMIX3.0-based DAO & NFT platform ‘NILE’ (NFT Is Life Evolution) starting today. The NFTs may be exchanged with ‘CROW,’ the key token of NIGHT CROWS, from April 1st.
At Taipei Game Show 2024, Wemade will be presenting the demo version of NIGHT CROWS. The show will be held at the Taipei Nangang Exhibition Center from January 25th to 28th.
Information on NIGHT CROWS can be found on the official website.
Website references
NIGHT CROWS Official website: https://nightcrows.com/preregister
NEITH NFT ‘The Night is Coming’ Preview: https://medium.com/nile-official/neith-nft-the-night-is-coming-preview-bd75718daa08
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240110750299/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Delivers Fourth Quantum Computer in Finland, Operational at Aalto University11.3.2026 11:32:00 CET | Press release
This is the fourth quantum computer deployed by IQM to customers in Finland to boost research and education in a growing ecosystem. The system named Aalto Q20 quantum computer is online at Aalto University and will enable students and scientists a unique first-hand access to a world-class quantum computer. The university will use the quantum computer to perform scientific experiments on advanced level and to support national and European quantum research activities. IQM Quantum Computers, the global leader in deployed on-premises, full-stack superconducting quantum computers, today announced the launch of Aalto Q20 quantum computer in Finland, reinforcing its commercial leadership in the quantum industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311215316/en/ Ribbon cutting of the Aalto Q20 quantum computer delivered by IQM. The 20-qubit system, which is operational at Aalto University, is the fourth quantum compute
Chiesi and Bespak Partner to Advance Carbon Minimal Inhaler Production With UK Manufacturing Site11.3.2026 11:00:00 CET | Press release
Highlights Agreement builds on existing Chiesi-Bespak collaboration, reinforcing a trusted relationship as Chiesi works to evolve a portfolio of extrafine formulation Carbon Minimal Inhalers1, ensuring patients retain continuity of care while reducing carbon emissionsBespak’s leadership in low-GWP propellant inhaler manufacturing along with significant expansion at its Holmes Chapel site strengthens Chiesi’s global supply chain resiliencePartnership aligns with the science-based climate commitments of both companies Chiesi Group ("Chiesi"), the international research focused biopharmaceutical company and a certified B Corp, and Bespak, the specialist inhalation CDMO focused on pulmonary and nasal drug delivery, today announced an expansion of their long-standing partnership, increasing pressurized metered dose inhaler (pMDI) manufacturing capacity at Bespak’s Holmes Chapel site to support the next phase of Chiesi’s Carbon Minimal Inhaler (CMI) program. This press release features multi
NTT DATA Unveils NVIDIA-Powered Enterprise AI Factories to Support Secure AI Adoption and Help Clients Drive Measurable ROI11.3.2026 11:00:00 CET | Press release
NTT DATA drives success in healthcare, manufacturing and other sectors with NVIDIA-powered technologies NTT DATA AI solutions now integrate NVIDIA AI Enterprise software, including NVIDIA NeMo and NIM Microservices to create a full-stack, production-ready, GPU-accelerated agentic AI platform NTT DATA, a global leader in AI, digital business and technology services, announced an initiative to deliver NVIDIA-powered enterprise AI factories that drive innovation and operational excellence for organizations worldwide. NTT DATA’s new enterprise AI factories provide full-stack, domain-specific solutions that integrate data, infrastructure, workflows and governance to give organizations a repeatable and production-ready operating model for enterprise AI. NTT DATA enterprise AI factories, powered by NVIDIA, are adaptive, intelligent and automated ecosystems designed to help clients accelerate return on investment by scaling enterprise AI efficiently and managing the full AI lifecycle end to en
Haleon Strengthens Commitment to China as Consumers Focus on Better Everyday Health11.3.2026 10:00:00 CET | Press release
£65m investment in new oral health manufacturing plant in Shanghai to support growth in the world’s largest gum health market Haleon aiming to extend gum health brand parodontax to 30 Chinese cities by end of 2027 - including its fastest growing cities – reaching aspirational shoppers in-store and online Custom designed taste, foamier sensation and premium packaging to appeal to local consumers Haleon, a consumer company that is solely focused on better everyday health, is investing £65 million in a new state-of-the-art oral health manufacturing site in Shanghai. The facility will support the expansion of its oral care portfolio – which includes the global brands Sensodyne and parodontax – into China’s fast-growing tier 2 and tier 3 cities, where rising incomes, growing awareness of everyday health and a shift towards trusted, branded products are reshaping consumer behaviour. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/202
Eurofins Biomnis Launches New Clinical LC‑MS/MS Method for the Detection of Cereulide Toxin in Stool Samples11.3.2026 09:00:00 CET | Press release
Eurofins Biomnis, a leading European provider of specialised clinical diagnostics services, and part of the global network of Eurofins laboratories, announces the successful development and validation of a new liquid chromatography tandem mass spectrometry (LC‑MS/MS) method for the detection and quantification of cereulide toxin in human stool samples. This innovation underlines Eurofins Biomnis’ diagnostic innovation, and its commitment to contributing its expertise to reducing diagnostic uncertainty with solutions that support clinicians and laboratories nationwide and internationally. Eurofins Biomnis has fully validated the method for human stool samples, taking into account matrix effects and meeting the requirements of ISO 15189 (with the exception of inter‑method comparison on pathological clinical samples). Cereulide, a toxin produced by specific strains of Bacillus cereus, has recently raised significant public attention following contamination events involving infant formula
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom